Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Fox Corp provided a status update on its pending acquisition of Roku, Inc., specifically addressing a putative class action lawsuit filed by a stockholder seeking to enjoin the merger. To avoid potential delays to the transaction, Fox is voluntarily providing supplemental disclosures to the Joint Proxy Statement/Prospectus ahead of the special meetings of stockholders scheduled for October 14, 2026.
Personalis announced the expiration of the Hart-Scott-Rodino (HSR) Act waiting period regarding its pending acquisition by Tempus AI, Inc. The expiration of the antitrust waiting period satisfies a key closing condition for the merger, which was originally announced on July 20, 2026. The transaction remains subject to approval by Personalis stockholders and other customary closing conditions.
Columbus Acquisition M&A Deal with WISeSat.Space Holdings Corp.
Columbus Acquisition Corp (CAC) completed its business combination with WISeSat.Space Holdings Corp. on October 1, 2026, following shareholder approval at an extraordinary general meeting. The combined company, renamed WISeSat.Space Holdings Corp., will begin trading on the Nasdaq under the ticker symbol 'SAIQ' on October 2, 2026.
Atlanticus Holdings Corporation, through its subsidiary Mercury Financial, LLC, sold the MERCURY word mark and related intellectual property to an unaffiliated third party for $27.5 million in cash. The company retained the underlying consumer credit card receivables and received a royalty-free license to continue using the mark for 12 months, followed by a five-year servicing period.
SRX Global committed $1.5 million to launch a new family of AI-powered, actively managed ETFs through its EMJX platform in partnership with Kupa Inc. The initial ETF, expected to launch in Q1 2027, will feature a digital asset hedging strategy, and the company intends to dividend its holdings from the launch directly to SRX shareholders.
Neighborhood Intelligence, Inc. closed a registered direct offering of 10,881,192 shares of common stock and 5,241,997 pre-funded warrants at a price of $2.76 per share/unit. The offering generated approximately $42.6 million in net proceeds, which the company intends to use to accelerate merger synergies and build inventory. Additionally, the company reduced its existing at-the-market (ATM) program capacity from $200 million to $75 million.
TELA Bio, Inc. received a formal notification from Nasdaq stating that the company has regained compliance with the minimum bid price requirement for continued listing. The matter is now closed, and the company's common stock will continue to trade on the Nasdaq Global Market under the symbol 'TELA'.
Kyntra Bio received a delisting determination from Nasdaq on September 30, 2026, for failing to meet the minimum total assets and revenue requirements under Listing Rule 5450(b). The company has requested a hearing before a Nasdaq Hearings Panel to seek an extension, which stays the suspension of its common stock pending a decision. Kyntra Bio is preparing a compliance plan but cannot guarantee the Panel will grant the request for continued listing.
Cirrus Logic M&A Deal with Inventvm Semiconductor S.r.l.
Cirrus Logic, Inc. has acquired Inventvm Semiconductor S.r.l., a fabless semiconductor company based in Italy specializing in mixed-signal power management and audio integrated circuits. The acquisition is intended to accelerate product development and expand engineering capacity in support of Cirrus Logic's long-term growth strategy. Financial terms of the transaction were not disclosed.
IES Holdings Signs $691M M&A Deal with DBM Global, Inc.
IES Holdings, Inc. completed its acquisition of DBM Global, Inc. for approximately $691 million, consisting of $545 million in cash and $146 million in IES common stock. The transaction establishes a new Structural line of business for IES, adding a major structural steel fabrication and erection platform with approximately 4,000 employees.
Principal Credit Real Estate Income Trust Capital Raise of $12.8M
Principal Credit Real Estate Income Trust raised approximately $12.85 million through the issuance of Class A and other common shares to anchor and third-party investors. The capital raise included $7 million from Class A shares at $21.5617 per share and $5.85 million from a continuous private offering of various common share classes.
Brandywine Operating Partnership Divestiture for $240M
Brandywine Realty Trust completed the sale of a 441,000 square foot office building at 3151 Market Street in Philadelphia for $240.0 million. The company received net proceeds of approximately $233.7 million and used a portion to retire a $57.3 million Commercial Property Assessed Clean Energy Loan that encumbered the property.
Third Point Private Capital Partners Capital Raise of $10M
Third Point Private Capital Partners sold 371,692 Class I common shares in an unregistered private placement for total consideration of $10 million. The offering was conducted under Section 4(a)(2) and Regulation D/S exemptions for accredited and non-U.S. investors. The fund also reported a Net Asset Value (NAV) per share of $26.90 as of August 31, 2026.
Campbell Fund Trust sold $6.09 million in Units of Beneficial Interest to existing and new unitholders in a private placement effective September 30, 2026. The sale included $1.77 million for Series A, $3.81 million for Series D, and $0.52 million for Series W units, issued under a Section 4(2) exemption from registration.
Fidelity Core Real Estate Fund Capital Raise of $26.5M
Fidelity Core Real Estate Fund issued a total of 2,289,716 Class I common shares to accredited investors across September and October 2026. The transactions included $2.1 million via a distribution reinvestment plan and $24.4 million in direct unregistered sales, totaling $26.5 million in proceeds.
Conduent Divestiture to Modaxo France Holdings SAS for $164M
Conduent completed the sale of its public transit and fare collection business to Modaxo for a base purchase price of $164 million. The company received $140 million in cash at closing, with the remaining balance subject to holdbacks and adjustments, and intends to use the net proceeds to repay its revolving credit facility.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. has filed a formal Notice of Variation to increase its offer to acquire all outstanding shares of Aurora Cannabis Inc. The enhanced offer provides total implied consideration of US$5.00 per share, consisting of 0.4013 Curaleaf shares and US$1.00 in cash, representing an 86% premium to Aurora's unaffected share price.
Bluerock Homes Trust Divestiture to unaffiliated third party for $8M
Bluerock Homes Trust completed the sale of its Lubbock-75 portfolio, consisting of 75 single-family residential units in Lubbock, Texas, for approximately $8.0 million. The disposition resulted in net proceeds of approximately $7.3 million to the company after closing costs and adjustments.
Hines Global Income Trust Announces $525M M&A Deal
Hines Global Income Trust completed three U.S. acquisitions totaling $525.3 million, including the Castings Commerce Center industrial property in Columbus ($117.0M), the 99 West Paces residential tower in Atlanta ($237.8M), and the Bishop Arts Portfolio mixed-use property in Dallas ($170.5M). These acquisitions expand the company's portfolio across high-conviction industrial, residential, and retail sectors.
Cottonwood Communities, Inc. issued and sold 216,192 shares of its Series A Convertible Preferred Stock in a private placement offering between September 18, 2026, and October 5, 2026. The company received aggregate proceeds of approximately $2.09 million from this tranche of the ongoing $200 million best-efforts private offering. The shares were sold to accredited investors at a purchase price of $10.00 per share.
Fortress Net Lease REIT issued and sold 8,864,594 common shares across multiple classes for gross proceeds of approximately $94.8 million. The shares were sold in an unregistered private placement based on the net asset value per share as of August 31, 2026.
Fortress Credit Realty Income Trust Capital Raise of $16.1M
Fortress Credit Realty Income Trust issued and sold 806,494 common shares across multiple classes for gross proceeds of approximately $16.1 million on October 1, 2026. The private placement was conducted at prices based on the net asset value per share as of August 31, 2026. Additionally, the company declared monthly distributions for all share classes payable to shareholders of record as of September 30, 2026.
Warner Bros. Discovery M&A Deal with Skydance Corporation
Warner Bros. Discovery, Inc. (WBD) completed its merger with Skydance Corporation (SKYD) on October 6, 2026, with WBD becoming a wholly owned subsidiary of SKYD. In connection with the closing, WBD repaid its existing first lien credit facilities and certain subsidiaries entered into supplemental indentures to guarantee SKYD's debt obligations.
Pyrophyte Acquisition Corp.'s sponsor, Pyrophyte Acquisition LLC, deposited $100,000 into the company's trust account to extend the deadline for completing an initial business combination. This represents the fourth monthly extension payment required to maintain the company's timeline through April 29, 2027.
ExchangeRight Income Fund's operating partnership amended its partnership agreement to create Class T Common Units. These units were specifically created to serve as consideration for the acquisition of a net-leased property to support the partnership's growth. The new units carry a fixed annual distribution rate of $1.650691 per unit and are subject to mandatory conversion into Class D Common Units upon certain events.
Nexentis Technologies amended several series of outstanding warrants to remove liability classification provisions and reclassify them as equity for accounting purposes. This action was taken specifically to help the company regain compliance with Nasdaq Listing Rule 5550(b)(1), which relates to minimum stockholders' equity requirements. The amendments do not change the exercise price, share count, or expiration dates of the warrants.
Repligen Corporation completed its acquisition of BioLife Solutions, Inc., a developer of cell processing tools for the cell and gene therapy market. Under the terms of the merger, BioLife stockholders received $11.25 in cash and 0.1442 shares of Repligen common stock for each share held. The deal expands Repligen's presence in the cell therapy workflow by adding BioLife's biopreservation media portfolio, including the CryoStor product line.
Counterparty
BioLife Solutions, Inc.
“BioLife’s highly-differentiated portfolio of products expands our presence in the rapidly growing cell therapy market, adding a deeply embedded, high-margin consumables business with attractive recurring revenue. Together, we are better positioned to support customers across critical stages of the cell therapy workflow and help advance the development and commercialization of next-generation therapies.”
Olivier Loeillot, President and Chief Executive Officer of Repligen
Biolife Solutions M&A Deal with Repligen Corporation
BioLife Solutions completed its merger with Repligen Corporation, becoming a wholly owned subsidiary of Repligen. BioLife stockholders received 0.1442 shares of Repligen common stock and $11.25 in cash for each share of BioLife common stock held. As a result of the completion, BioLife's common stock will be delisted from the Nasdaq Stock Market.
Paramount Skydance M&A Deal with Warner Bros. Discovery, Inc.
Paramount Skydance Corp (now Skydance Corporation) completed its acquisition of Warner Bros. Discovery, Inc., creating a combined global entertainment leader. In connection with the closing, the company issued $41.4 billion in senior secured notes and transferred its stock listing to the NYSE under the ticker 'SKYD'.
Bluejay Diagnostics announced baseline clinical characteristics from its SYMON-II clinical validation study, which is evaluating the Symphony IL-6 Test for mortality risk in sepsis patients. The study includes 777 evaluable patients with an 18% mortality rate, providing a diverse dataset to support the company's planned regulatory submission. The data showed that non-survivors had higher baseline illness severity, with septic shock present in 56.4% of that group.